No registrations found.
ID
Source
Brief title
Health condition
Outpatients with psychotic disorders and comorbid substance abuse having an indication for antipsychotic depot medication
Sponsors and support
Avocadostraat 33
2552 HS Den Haag
Telefoon: 070-391 76 11
b.vanderhoorn@palier.nl
Intervention
Outcome measures
Primary outcome
The number (percentage) of accepted depot injections.
Secondary outcome
1. Longest uninterrupted period of depot medication acceptance;
2. Time expired before depot is taken;
3. Effort initiated by clinicians to provide depot;
4. Psychiatric symptomatology (PANSS);
5. Health, psychological and social functioning (HoNOS);
6. Substance use (ASI, Section III, CIDI-SAM, verified by urine-analysis);
7. Subjective Quality of Life (MANSA);
8. Antipsychotic Side-effects (ASC);
9. Cost Utility (TiC-P, EQ-5D);
10. Impulsivity (DII);
11. Attitudes towards medication (ROMI);
12. Attitudes towards M4M.
Background summary
Money for Medication (M4M) is a randomized controlled study on the effectivenes of financial incentives in improving adherence with antipsychotic depot medication in patients with psychotic disorders and co-morbid substance abuse.
Study objective
Providing M4M will increase patients acceptance of their prescribed antipsychotic depot medication.
Study design
1. Baseline (Month 0);
2. End of intervention (Month 12);
3. Follow-up (Month 18).
Intervention
Patients assigned to the intervention group (M4M) will receive treatment as usual, plus a financial incentive for each time they accept their prescribed depot of antipsychotic medication. All patients in the intervention group (M4M) will receive an average maximum of 30 euro per month. The amount of money they will receive is dependent upon the frequency of the depot. For example, a patient who receives a two-weekly depot will receive 15 euro per accepted depot. A patient who receives a three-weekly depot will receive 22.50 euro for each accepted depot etcetera.
Charlotte Audier
Erasmus MC, Kamer DP-0404
Rotterdam 3015 CE
The Netherlands
c.audier@palier.nl
Charlotte Audier
Erasmus MC, Kamer DP-0404
Rotterdam 3015 CE
The Netherlands
c.audier@palier.nl
Inclusion criteria
1. Age between 18 and 65 years;
2. Psychotic disorder (including schizophrenia, schizoaffective disorder or other psychotic disorders);
3. Substance use disorder (alcohol and/or drugs);
4. Indication for antipsychotic depot medication;
5. Outpatient treatment (either starting outpatient treatment or being in outpatient treatment for at least four months and having missed prescribed depot medications;
6. Given informed consent.
Exclusion criteria
1. Not meeting all inclusion criteria;
2. Inability to participate in this study due to cognitive impairments;
3. And/or an inability to understand the Dutch language sufficiently to participate in this study.
Design
Recruitment
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL2225 |
| NTR-old | NTR2350 |
| CCMO | NL31406.097.10 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |
| OMON | NL-OMON34809 |